Jefferies Group LLC Agenus Inc Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $31,483 - $50,437	-16,063 Reduced 50.94%	15,470 $0
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $40,992 - $83,247	31,533 New	31,533 $16,000
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $163,205 - $240,988	-69,449 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $202,791 - $398,637	69,449 New	69,449 $91,000
Q3 2019 Nov 13, 2019	SELL	$2.17 - $3.14 $31,465 - $45,530	-14,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $36,685 - $44,080	14,500 New	14,500 $44,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $103,391 - $153,646	-41,192 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.59 - $2.66 $199,276 - $333,380	-125,331 Reduced 75.26%	41,192 $98,000
Q3 2018 Nov 14, 2018	BUY	$1.59 - $2.42 $167,145 - $254,397	105,123 Added 171.21%	166,523 $356,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $138,764 - $285,510	61,400 New	61,400 $139,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.